StemCells, Inc. Reports Second Quarter 2015 Financial Results, Business Update and Clinical Program Highlights

Go back to StemCells, Inc. Reports Second Quarter 2015 Financial Results, Business Update and Clinical Program Highlights
STEMCELLS (NYSE: STEM) Delayed: 7.63 -0.43 (5.33%)
Previous Close $8.06    52 Week High $3.08 
Open $7.74    52 Week Low $0.21 
Day High $8.13    P/E N/A 
Day Low $7.63    EPS $-0.49 
Volume 63,450